{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:04:26Z","timestamp":1792512266223,"version":"4.5.0"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07653-2","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:56:01Z","timestamp":1769702161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Enhancing osteoporosis treatment: emerging roles of engineered exosomes in bone regeneration and repair"],"prefix":"10.1186","volume":"24","author":[{"given":"Hongtao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minshan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"10329","key":"7653_CR1","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0140-6736(21)02646-5","volume":"399","author":"IR Reid","year":"2022","unstructured":"Reid IR, Billington EO. Drug therapy for osteoporosis in older adults. Lancet. 2022;399(10329):1080\u201392. https:\/\/doi.org\/10.1016\/S0140-6736(21)02646-5","journal-title":"Lancet"},{"issue":"21","key":"7653_CR2","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","volume":"389","author":"MD Walker","year":"2023","unstructured":"Walker MD, Shane E. Postmenopausal osteoporosis. N Engl J Med. 2023;389(21):1979\u201391. https:\/\/doi.org\/10.1056\/NEJMcp2307353","journal-title":"N Engl J Med"},{"issue":"1","key":"7653_CR3","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC202401160","volume":"177","author":"KE Ensrud","year":"2024","unstructured":"Ensrud KE, Crandall CJ. Osteoporosis. Ann Intern Med. 2024;177(1):ITC1\u201316. https:\/\/doi.org\/10.7326\/AITC202401160","journal-title":"Ann Intern Med"},{"key":"7653_CR4","doi-asserted-by":"publisher","unstructured":"Masurkar PP, Rege S. Marginal health care expenditures and health-related quality of life burden in patients with osteoporosis in the United States. J Am Pharm Assoc. 2003). 2025;65(2):102315. https:\/\/doi.org\/10.1016\/j.japh.2024.102315","DOI":"10.1016\/j.japh.2024.102315"},{"issue":"10","key":"7653_CR5","doi-asserted-by":"publisher","first-page":"e10800","DOI":"10.1002\/jbm4.10800","volume":"7","author":"H Wadhwa","year":"2023","unstructured":"Wadhwa H, Wu JY, Lee JS, et al. Anabolic and antiresorptive osteoporosis treatment: trends, costs, and sequence in a commercially insured population, 2003-2021. JBMR Plus. 2023;7(10):e10800. https:\/\/doi.org\/10.1002\/jbm4.10800","journal-title":"JBMR Plus"},{"issue":"1","key":"7653_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s13018-023-03920-4","volume":"18","author":"C Yuan","year":"2023","unstructured":"Yuan C, Liang Y, Zhu K, et al. Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis. J Orthop Surg Res. 2023;18(1):447. https:\/\/doi.org\/10.1186\/s13018-023-03920-4","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"7653_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00774-024-01536-0","volume":"43","author":"K Ebina","year":"2025","unstructured":"Ebina K, Etani Y, Noguchi T, et al. Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis. J Bone Min Metab. 2025;43(1):3\u20139. https:\/\/doi.org\/10.1007\/s00774-024-01536-0","journal-title":"J Bone Min Metab"},{"issue":"1","key":"7653_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/jama.2020.2923","volume":"325","author":"KE Ensrud","year":"2021","unstructured":"Ensrud KE. Bisphosphonates for postmenopausal osteoporosis. Jama. 2021;325(1):96. https:\/\/doi.org\/10.1001\/jama.2020.2923","journal-title":"Jama"},{"issue":"3","key":"7653_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00774-015-0670-6","volume":"34","author":"A Sugie-Oya","year":"2016","unstructured":"Sugie-Oya A, Takakura A, Takao-Kawabata R, et al. Comparison of treatment effects of teriparatide and the bisphosphonate risedronate in an aged, osteopenic, ovariectomized rat model under various clinical conditions. J Bone Min Metab. 2016;34(3):303\u201314. https:\/\/doi.org\/10.1007\/s00774-015-0670-6","journal-title":"J Bone Min Metab"},{"issue":"2","key":"7653_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","volume":"177","author":"DK Jeppesen","year":"2019","unstructured":"Jeppesen DK, Fenix AM, Franklin JL, et al. Reassessment of exosome composition. Cell. 2019;177(2):428\u201345.e18. https:\/\/doi.org\/10.1016\/j.cell.2019.02.029","journal-title":"Cell"},{"key":"7653_CR11","doi-asserted-by":"publisher","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478): null. doi: https:\/\/doi.org\/10.1126\/science.aau6977","DOI":"10.1126\/science.aau6977"},{"issue":"5","key":"7653_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/jcmm.13039","volume":"21","author":"Y Xie","year":"2017","unstructured":"Xie Y, Chen Y, Zhang L, et al. The roles of bone-derived exosomes and exosomal microRNAs in regulating bone remodelling. J Cell Mol Med. 2017;21(5):1033\u201341. https:\/\/doi.org\/10.1111\/jcmm.13039","journal-title":"J Cell Mol Med"},{"issue":"1","key":"7653_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12964-023-01431-7","volume":"22","author":"P Wang","year":"2024","unstructured":"Wang P, Shao W, Li Z, et al. Non-bone-derived exosomes: a new perspective on regulators of bone homeostasis. Cell Commun Signal. 2024;22(1):70. https:\/\/doi.org\/10.1186\/s12964-023-01431-7","journal-title":"Cell Commun Signal"},{"issue":"1","key":"7653_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41413-023-00313-5","volume":"12","author":"F Fang","year":"2024","unstructured":"Fang F, Yang J, Wang J, et al. The role and applications of extracellular vesicles in osteoporosis. Bone Res. 2024;12(1):4. https:\/\/doi.org\/10.1038\/s41413-023-00313-5","journal-title":"Bone Res"},{"key":"7653_CR15","doi-asserted-by":"publisher","unstructured":"Zhivodernikov M IV, Kirichenko YV, TV, et al. Exosomes as a potential therapeutic approach in osteoimmunology. Front Immunol. 2023;14:1309015. https:\/\/doi.org\/10.3389\/fimmu.2023.1309015","DOI":"10.3389\/fimmu.2023.1309015"},{"key":"7653_CR16","doi-asserted-by":"publisher","unstructured":"Kim NH, Kim J, Lee JY, et al. Application of milk exosomes for musculoskeletal health: talking points in Recent outcomes. Nutrients. 2023;15(21). https:\/\/doi.org\/10.3390\/nu15214645","DOI":"10.3390\/nu15214645"},{"issue":"10109","key":"7653_CR17","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/S0140-6736(17)32850-7","volume":"390","author":"NC Harvey","year":"2017","unstructured":"Harvey NC, McCloskey E, Kanis JA, et al. Bisphosphonates in osteoporosis: nice and easy? Lancet. 2017;390(10109):2243\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(17)32850-7","journal-title":"Lancet"},{"issue":"1","key":"7653_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1056\/NEJM200507073530120","volume":"353","author":"BG Durie","year":"2005","unstructured":"Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med. 2005;353(1):99\u2013102; discussion 99-102. doi: https:\/\/doi.org\/10.1056\/NEJM200507073530120","journal-title":"N Engl J Med"},{"issue":"1","key":"7653_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00198-009-0930-1","volume":"21","author":"FE Cott\u00e9","year":"2010","unstructured":"Cott\u00e9 FE, Fardellone P, Mercier F, et al. Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis. Osteoporos Int. 2010;21(1):145\u201355. https:\/\/doi.org\/10.1007\/s00198-009-0930-1","journal-title":"Osteoporos Int"},{"issue":"5","key":"7653_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/ki.2008.193","volume":"74","author":"S Boonen","year":"2008","unstructured":"Boonen S, Sellmeyer DE, Lippuner K, et al. Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women. Kidney Int. 2008;74(5):641\u201348. https:\/\/doi.org\/10.1038\/ki.2008.193","journal-title":"Kidney Int"},{"issue":"1","key":"7653_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3803\/EnM.2024.2125","volume":"40","author":"J Ha","year":"2025","unstructured":"Ha J, Lee YJ, Kim J, et al. Long-term efficacy and safety of denosumab: insights beyond 10 years of use. Endocrinol Metab (seoul). 2025;40(1):47\u201356. https:\/\/doi.org\/10.3803\/EnM.2024.2125","journal-title":"Endocrinol Metab (seoul)"},{"key":"7653_CR22","doi-asserted-by":"publisher","first-page":"564781","DOI":"10.3389\/fendo.2021.564781","volume":"12","author":"J Mehta","year":"2021","unstructured":"Mehta J, Kling JM, Risks MJE. Benefits, and treatment modalities of menopausal hormone therapy: current concepts. Front Endocrinol (lausanne). 2021;12:564781. https:\/\/doi.org\/10.3389\/fendo.2021.564781","journal-title":"Front Endocrinol (lausanne)"},{"issue":"2","key":"7653_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/GCO.0000000000000843","volume":"35","author":"AJ Voedisch","year":"2023","unstructured":"Voedisch AJ. Counseling on hormone replacement therapy: the real risks and benefits. Curr Opin Obstet Gynecol. 2023;35(2):154\u201359. https:\/\/doi.org\/10.1097\/GCO.0000000000000843","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"9","key":"7653_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/jbmr\/zjaf037","volume":"40","author":"S Kumar","year":"2025","unstructured":"Kumar S, Wang M, Kim AS, Center JR, McDonald MM, Girgis CM. Denosumab discontinuation in the clinic: implications of rebound bone turnover and emerging strategies to prevent bone loss and fractures. J Bone Min Res. 2025;40(9):1017\u201334. https:\/\/doi.org\/10.1093\/jbmr\/zjaf037","journal-title":"J Bone Min Res"},{"issue":"8","key":"7653_CR25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1210\/js.2018-00118","volume":"2","author":"AV Haas","year":"2018","unstructured":"Haas AV, LeBoff MS. Osteoanabolic agents for osteoporosis. J Endocr Soc. 2018;2(8):922\u201332. https:\/\/doi.org\/10.1210\/js.2018-00118","journal-title":"J Endocr Soc"},{"issue":"16","key":"7653_CR26","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 2016;375(16):1532\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1607948","journal-title":"N Engl J Med"},{"issue":"7","key":"7653_CR27","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1161\/ATVBAHA.119.312371","volume":"39","author":"K Asadipooya","year":"2019","unstructured":"Asadipooya K, Weinstock A. Cardiovascular Outcomes of Romosozumab and Protective Role of Alendronate. Arterioscler Thromb Vasc Biol. 2019;39(7):1343\u201350. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312371","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7653_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01936-y","author":"DL Kendler","year":"2021","unstructured":"Kendler DL, Cosman F, Stad RK, et al. Denosumab in the treatment of osteoporosis: 10 Years Later: a Narrative review. Adv Ther. 2021. https:\/\/doi.org\/10.1007\/s12325-021-01936-y","journal-title":"Adv Ther"},{"issue":"4","key":"7653_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ecl.2024.08.002","volume":"53","author":"S Jain","year":"2024","unstructured":"Jain S. Prevention and management of denosumab discontinuation rebound fractures. Endocrinol Metab Clin N Am. 2024;53(4):559\u201383. https:\/\/doi.org\/10.1016\/j.ecl.2024.08.002","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"11","key":"7653_CR30","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s00198-020-05507-9","volume":"31","author":"G Koller","year":"2020","unstructured":"Koller G, Goetz V, Vandermeer B, et al. Persistence and adherence to parenteral osteoporosis therapies: a systematic review. Osteoporos Int. 2020;31(11):2093\u2013102. https:\/\/doi.org\/10.1007\/s00198-020-05507-9","journal-title":"Osteoporos Int"},{"issue":"1","key":"7653_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40364-022-00378-0","volume":"10","author":"K Sankar","year":"2022","unstructured":"Sankar K, Ye JC, Li Z, et al. The role of biomarkers in personalized immunotherapy. Biomark Res. 2022;10(1):32. https:\/\/doi.org\/10.1186\/s40364-022-00378-0","journal-title":"Biomark Res"},{"issue":"23","key":"7653_CR32","doi-asserted-by":"publisher","first-page":"null","DOI":"10.3390\/ijms21238992","volume":"21","author":"A Suzuki","year":"2020","unstructured":"Suzuki A, Minamide M, Iwaya C, et al. Role of metabolism in bone development and homeostasis. Int J Mol Sci. 2020;21(23):null. https:\/\/doi.org\/10.3390\/ijms21238992","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7653_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.pop.2024.04.005","volume":"51","author":"LL Seemann","year":"2024","unstructured":"Seemann LL, Hanos CT, Pujalte GGA. Metabolic bone disease. Prim Care. 2024;51(3):445\u201354. https:\/\/doi.org\/10.1016\/j.pop.2024.04.005","journal-title":"Prim Care"},{"issue":"6","key":"7653_CR34","doi-asserted-by":"publisher","first-page":"null","DOI":"10.3390\/ijms22062851","volume":"22","author":"DS Amarasekara","year":"2021","unstructured":"Amarasekara DS, Kim S, Rho J. Regulation of osteoblast differentiation by cytokine networks. Int J Mol Sci. 2021;22(6):null. https:\/\/doi.org\/10.3390\/ijms22062851","journal-title":"Int J Mol Sci"},{"key":"7653_CR35","doi-asserted-by":"publisher","first-page":"16009","DOI":"10.1038\/boneres.2016.9","volume":"4","author":"M Wu","year":"2016","unstructured":"Wu M, Chen G, Li YP. TGF-\u03b2 and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 2016;4:16009. https:\/\/doi.org\/10.1038\/boneres.2016.9","journal-title":"Bone Res"},{"issue":"5","key":"7653_CR36","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI28551","volume":"116","author":"V Krishnan","year":"2006","unstructured":"Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006;116(5):1202\u201309. https:\/\/doi.org\/10.1172\/JCI28551","journal-title":"J Clin Invest"},{"issue":"3","key":"7653_CR37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s00774-020-01176-0","volume":"39","author":"S Tanaka","year":"2021","unstructured":"Tanaka S, Matsumoto T. Sclerostin: from bench to bedside. J Bone Min Metab. 2021;39(3):332\u201340. https:\/\/doi.org\/10.1007\/s00774-020-01176-0","journal-title":"J Bone Min Metab"},{"issue":"1","key":"7653_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12902-024-01591-8","volume":"24","author":"W Li","year":"2024","unstructured":"Li W, Wang W, Zhang M, et al. Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis. BMC Endocr Disord. 2024;24(1):55. https:\/\/doi.org\/10.1186\/s12902-024-01591-8","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"7653_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13287-023-03317-4","volume":"14","author":"X He","year":"2023","unstructured":"He X, Wang Y, Liu Z, et al. Osteoporosis treatment using stem cell-derived exosomes: a systematic review and meta-analysis of preclinical studies. STEM Cell Res Ther. 2023;14(1):72. https:\/\/doi.org\/10.1186\/s13287-023-03317-4","journal-title":"STEM Cell Res Ther"},{"key":"7653_CR40","doi-asserted-by":"publisher","unstructured":"Gao Y, Chen N, Fu Z, et al. Progress of Wnt signaling pathway in osteoporosis. Biomolecules. 2023;13(3). https:\/\/doi.org\/10.3390\/biom13030483","DOI":"10.3390\/biom13030483"},{"key":"7653_CR41","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fcell.2018.00170","volume":"6","author":"KS Houschyar","year":"2018","unstructured":"Houschyar KS, Tapking C, Borrelli MR, et al. Wnt pathway in bone repair and regeneration - what do we know so far. Front Cell Dev Biol. 2018;6:170. https:\/\/doi.org\/10.3389\/fcell.2018.00170","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"7653_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41413-024-00342-8","volume":"12","author":"L Hu","year":"2024","unstructured":"Hu L, Chen W, Qian A, et al. Wnt\/\u03b2-catenin signaling components and mechanisms in bone formation, homeostasis, and disease. Bone Res. 2024;12(1):39. https:\/\/doi.org\/10.1038\/s41413-024-00342-8","journal-title":"Bone Res"},{"issue":"5","key":"7653_CR43","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.mporth.2021.07.006","volume":"35","author":"CM Peake","year":"2021","unstructured":"Peake CM, Shah K, Solan M. Bone metabolism and the receptor activator of nuclear factor-\u03baB ligand (RANKL) pathway: a comprehensive review. Orthop And Trauma. 2021;35(5):297\u2013304. https:\/\/doi.org\/10.1016\/j.mporth.2021.07.006","journal-title":"Orthop And Trauma"},{"issue":"1","key":"7653_CR44","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1186\/s13578-021-00599-0","volume":"11","author":"J Cheng","year":"2021","unstructured":"Cheng J, Duan L, Yu Y, et al. Bone marrow mesenchymal stem cells promote prostate cancer cell stemness via cell-cell contact to activate the Jagged1\/Notch1 pathway. Cell & Biosci. 2021;11(1):0\u20130. https:\/\/doi.org\/10.1186\/s13578-021-00599-0","journal-title":"Cell & Biosci"},{"issue":"4","key":"7653_CR45","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1359\/jbmr.060109","volume":"21","author":"M Phimphilai","year":"2006","unstructured":"Phimphilai M, Zhao Z, Boules H, et al. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype. J Bone Min Res. 2006;21(4):637\u201346. https:\/\/doi.org\/10.1359\/jbmr.060109","journal-title":"J Bone Min Res"},{"key":"7653_CR46","doi-asserted-by":"publisher","first-page":"883228","DOI":"10.3389\/fcell.2022.883228","volume":"10","author":"CP Yan","year":"2022","unstructured":"Yan CP, Wang XK, Jiang K, et al. \u03b2-Ecdysterone Enhanced bone regeneration through the BMP-2\/SMAD\/RUNX2\/Osterix signaling pathway. Front Cell Dev Biol. 2022;10:883228. https:\/\/doi.org\/10.3389\/fcell.2022.883228","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"7653_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jdsr.2009.10.003","volume":"46","author":"E Jimi","year":"2010","unstructured":"Jimi E, Hirata S, Shin M, et al. Molecular mechanisms of BMP-induced bone formation: cross-talk between BMP and NF-\u03baB signaling pathways in osteoblastogenesis. Jpn Dent Sci Rev. 2010;46(1):33\u201342. https:\/\/doi.org\/10.1016\/j.jdsr.2009.10.003","journal-title":"Jpn Dent Sci Rev"},{"issue":"12","key":"7653_CR48","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.4049\/jimmunol.0904033","volume":"184","author":"C Liu","year":"2010","unstructured":"Liu C, Walter TS, Huang P, et al. Structural and functional insights of RANKL-RANK interaction and signaling. J Immunol. 2010;184(12):6910\u201319. https:\/\/doi.org\/10.4049\/jimmunol.0904033","journal-title":"J Immunol"},{"key":"7653_CR49","doi-asserted-by":"publisher","first-page":"903657","DOI":"10.3389\/fcell.2022.903657","volume":"10","author":"L Marcadet","year":"2022","unstructured":"Marcadet L, Bouredji Z, Argaw A, et al. The roles of RANK\/RANKL\/OPG in cardiac, skeletal, and smooth muscles in health and disease. Front Cell Dev Biol. 2022;10:903657. https:\/\/doi.org\/10.3389\/fcell.2022.903657","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"7653_CR50","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41419-020-03046-z","volume":"11","author":"J Guo","year":"2020","unstructured":"Guo J, Ren R, Sun K, et al. Perk controls bone homeostasis through the regulation of osteoclast differentiation and function. Cell Death Dis. 2020;11(10):847. https:\/\/doi.org\/10.1038\/s41419-020-03046-z","journal-title":"Cell Death Dis"},{"issue":"3","key":"7653_CR51","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1182\/blood-2004-09-3662","volume":"106","author":"NK Lee","year":"2005","unstructured":"Lee NK, Choi YG, Baik JY, et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood. 2005;106(3):852\u201359. https:\/\/doi.org\/10.1182\/blood-2004-09-3662","journal-title":"Blood"},{"key":"7653_CR52","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41232-019-0111-3","volume":"40","author":"T Ono","year":"2020","unstructured":"Ono T, Hayashi M, Sasaki F, et al. RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen. 2020;40:2. https:\/\/doi.org\/10.1186\/s41232-019-0111-3","journal-title":"Inflamm Regen"},{"key":"7653_CR53","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fimmu.2014.00511","volume":"5","author":"MC Walsh","year":"2014","unstructured":"Walsh MC, Choi Y. Biology of the RANKL-RANK-OPG System in immunity, bone, and beyond. Front Immunol. 2014;5:511. https:\/\/doi.org\/10.3389\/fimmu.2014.00511","journal-title":"Front Immunol"},{"key":"7653_CR54","doi-asserted-by":"publisher","unstructured":"De Leon-Oliva D, Barrena-Bl\u00e1zquez, L J-\u00c1, et al. The RANK-RANKL-OPG System: a Multifaceted regulator of homeostasis, immunity, and cancer. Medicina (Kaunas). 2023;59(10). https:\/\/doi.org\/10.3390\/medicina59101752","DOI":"10.3390\/medicina59101752"},{"key":"7653_CR55","doi-asserted-by":"publisher","unstructured":"Elahmer NR, Wong SK, Mohamed N, et al. Mechanistic insights and therapeutic strategies in osteoporosis: a comprehensive review. Biomedicines. 2024;12(8). https:\/\/doi.org\/10.3390\/biomedicines12081635","DOI":"10.3390\/biomedicines12081635"},{"issue":"1","key":"7653_CR56","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s11658-022-00371-3","volume":"27","author":"B Liang","year":"2022","unstructured":"Liang B, Burley G, Lin S, et al. Osteoporosis pathogenesis and treatment: existing and emerging avenues. Cell Mol Biol Lett. 2022;27(1):72. https:\/\/doi.org\/10.1186\/s11658-022-00371-3","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"7653_CR57","doi-asserted-by":"publisher","first-page":"null","DOI":"10.3390\/jcm10010152","volume":"10","author":"AD Anastasilakis","year":"2021","unstructured":"Anastasilakis AD, Makras P, Yavropoulou MP, et al. Denosumab discontinuation and the rebound phenomenon: a Narrative review. J Clin Med. 2021;10(1):null. https:\/\/doi.org\/10.3390\/jcm10010152","journal-title":"J Clin Med"},{"issue":"6","key":"7653_CR58","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s11914-023-00824-4","volume":"21","author":"HM Torres","year":"2023","unstructured":"Torres HM, Arnold KM, Oviedo M, et al. Inflammatory processes affecting bone health and repair. Curr Osteoporos Rep. 2023;21(6):842\u201353. https:\/\/doi.org\/10.1007\/s11914-023-00824-4","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"7653_CR59","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007;7(4):292\u2013304. https:\/\/doi.org\/10.1038\/nri2062","journal-title":"Nat Rev Immunol"},{"issue":"Suppl, 1","key":"7653_CR60","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1002\/eji.200737400","volume":"37","author":"RM Steinman","year":"2007","unstructured":"Steinman RM. Dendritic cells: understanding immunogenicity. Eur J Immunol. 2007;37(Suppl, 1):S53\u201360. https:\/\/doi.org\/10.1002\/eji.200737400","journal-title":"Eur J Immunol"},{"key":"7653_CR61","doi-asserted-by":"publisher","unstructured":"Kawaguchi M, Adachi M, Oda N, et al. IL-17 cytokine family. J Allergy Clin Immunol. 2004 1274;114(6):1265\u201373; quiz https:\/\/doi.org\/10.1016\/j.jaci.2004.10.019","DOI":"10.1016\/j.jaci.2004.10.019"},{"issue":"9","key":"7653_CR62","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1136\/annrheumdis-2011-201052","volume":"71","author":"N Kong","year":"2012","unstructured":"Kong N, Lan Q, Su W, et al. Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells. Ann Rheum Dis. 2012;71(9):1567\u201372. https:\/\/doi.org\/10.1136\/annrheumdis-2011-201052","journal-title":"Ann Rheum Dis"},{"issue":"561","key":"7653_CR63","doi-asserted-by":"publisher","first-page":"null","DOI":"10.1126\/scitranslmed.aba5942","volume":"12","author":"SA Rajakumar","year":"2020","unstructured":"Rajakumar SA, Papp E, Lee KK, et al. B cell acute lymphoblastic leukemia cells mediate RANK-RANKL-dependent bone destruction. Sci Transl Med. 2020;12(561):null. https:\/\/doi.org\/10.1126\/scitranslmed.aba5942","journal-title":"Sci Transl Med"},{"key":"7653_CR64","doi-asserted-by":"publisher","first-page":"965258","DOI":"10.3389\/fendo.2022.965258","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Gao R, Rong X, et al. Immunoporosis: role of immune system in the pathophysiology of different types of osteoporosis. Front Endocrinol (lausanne). 2022;13:965258. https:\/\/doi.org\/10.3389\/fendo.2022.965258","journal-title":"Front Endocrinol (lausanne)"},{"issue":"1","key":"7653_CR65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1302\/2046-3758.101.BJR-2020-0273.R1","volume":"10","author":"J Li","year":"2021","unstructured":"Li J, Ho WTP, Liu C, et al. The role of gut microbiota in bone homeostasis. Bone Joint Res. 2021;10(1):51\u201359. https:\/\/doi.org\/10.1302\/2046-3758.101.BJR-2020-0273.R1","journal-title":"Bone Joint Res"},{"key":"7653_CR66","doi-asserted-by":"publisher","first-page":"877776","DOI":"10.3389\/fmicb.2022.877776","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wang X, Zhang C, et al. Gut microbiota and bone diseases: a growing partnership. Front Microbiol. 2022;13:877776. https:\/\/doi.org\/10.3389\/fmicb.2022.877776","journal-title":"Front Microbiol"},{"issue":"9","key":"7653_CR67","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s10068-024-01620-1","volume":"33","author":"YT Kim","year":"2024","unstructured":"Kim YT, Mills DA. Exploring the gut microbiome: probiotics, prebiotics, synbiotics, and postbiotics as key players in human health and disease improvement. Food Sci Biotechnol. 2024;33(9):2065\u201380. https:\/\/doi.org\/10.1007\/s10068-024-01620-1","journal-title":"Food Sci Biotechnol"},{"issue":"14","key":"7653_CR68","doi-asserted-by":"publisher","first-page":"null","DOI":"10.3390\/ijms20143576","volume":"20","author":"TS Agidigbi","year":"2019","unstructured":"Agidigbi TS, Kim C. Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-Mediated osteoclast diseases. Int J Mol Sci. 2019;20(14):null. https:\/\/doi.org\/10.3390\/ijms20143576","journal-title":"Int J Mol Sci"},{"key":"7653_CR69","doi-asserted-by":"publisher","unstructured":"Liu H, Liu L, Rosen CJ. PTH and the regulation of mesenchymal cells within the bone marrow niche. Cells. 2024;13(5). https:\/\/doi.org\/10.3390\/cells13050406","DOI":"10.3390\/cells13050406"},{"key":"7653_CR70","doi-asserted-by":"publisher","unstructured":"Seely KD, Kotelko CA, Douglas H, et al. The human gut microbiota: a key Mediator of osteoporosis and osteogenesis. Int J Mol Sci. 2021;22(17). https:\/\/doi.org\/10.3390\/ijms22179452","DOI":"10.3390\/ijms22179452"},{"issue":"1","key":"7653_CR71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41413-023-00264-x","volume":"11","author":"Z Lyu","year":"2023","unstructured":"Lyu Z, Hu Y, Guo Y, et al. Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis. Bone Res. 2023;11(1):31. https:\/\/doi.org\/10.1038\/s41413-023-00264-x","journal-title":"Bone Res"},{"key":"7653_CR72","doi-asserted-by":"publisher","unstructured":"Torrecillas-Baena B, Pulido-Escribano V, Dorado G, et al. Clinical potential of mesenchymal stem cell-derived exosomes in bone regeneration. J Clin Med. 2023;12(13). https:\/\/doi.org\/10.3390\/jcm12134385","DOI":"10.3390\/jcm12134385"},{"key":"7653_CR73","doi-asserted-by":"publisher","first-page":"984131","DOI":"10.3389\/fchem.2022.984131","volume":"10","author":"J Zhuang","year":"2022","unstructured":"Zhuang J, Hang R, Sun R, et al. Multifunctional exosomes derived from bone marrow stem cells for fulfilled osseointegration. Front Chem. 2022;10:984131. https:\/\/doi.org\/10.3389\/fchem.2022.984131","journal-title":"Front Chem"},{"issue":"1","key":"7653_CR74","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12943-022-01671-0","volume":"21","author":"QF Han","year":"2022","unstructured":"Han QF, Li WJ, Hu KS, et al. Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer. Mol Cancer. 2022;21(1):207. https:\/\/doi.org\/10.1186\/s12943-022-01671-0","journal-title":"Mol Cancer"},{"issue":"2","key":"7653_CR75","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s13346-022-01225-3","volume":"13","author":"M Dimik","year":"2023","unstructured":"Dimik M, Abeysinghe P, Logan J, et al. The exosome: a review of current therapeutic roles and capabilities in human reproduction. Drug Deliv Transl Res. 2023;13(2):473\u2013502. https:\/\/doi.org\/10.1007\/s13346-022-01225-3","journal-title":"Drug Deliv Transl Res"},{"issue":"10","key":"7653_CR76","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1182\/blood-2004-03-0824","volume":"104","author":"AE Morelli","year":"2004","unstructured":"Morelli AE, Larregina AT, Shufesky WJ, et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 2004;104(10):3257\u201366. https:\/\/doi.org\/10.1182\/blood-2004-03-0824","journal-title":"Blood"},{"issue":"1","key":"7653_CR77","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12964-020-00581-2","volume":"18","author":"W Wang","year":"2020","unstructured":"Wang W, Zhu N, Yan T, et al. The crosstalk: exosomes and lipid metabolism. Cell Commun Signal. 2020;18(1):119. https:\/\/doi.org\/10.1186\/s12964-020-00581-2","journal-title":"Cell Commun Signal"},{"key":"7653_CR78","doi-asserted-by":"publisher","unstructured":"Zeng H, Guo S, Ren X, et al. Current strategies for exosome cargo loading and targeting delivery. Cells. 2023;12(10). https:\/\/doi.org\/10.3390\/cells12101416","DOI":"10.3390\/cells12101416"},{"issue":"1","key":"7653_CR79","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12964-024-01521-0","volume":"22","author":"M Xiong","year":"2024","unstructured":"Xiong M, Chen Z, Tian J, et al. Exosomes derived from programmed cell death: mechanism and biological significance. Cell Commun Signal. 2024;22(1):156. https:\/\/doi.org\/10.1186\/s12964-024-01521-0","journal-title":"Cell Commun Signal"},{"issue":"4","key":"7653_CR80","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00430-020-00673-3","volume":"209","author":"D Kummer","year":"2020","unstructured":"Kummer D, Steinbacher T, Schwietzer MF, et al. Tetraspanins: integrating cell surface receptors to functional microdomains in homeostasis and disease. Med Microbiol Immunol. 2020;209(4):397\u2013405. https:\/\/doi.org\/10.1007\/s00430-020-00673-3","journal-title":"Med Microbiol Immunol"},{"issue":"10","key":"7653_CR81","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nrm1736","volume":"6","author":"ME Hemler","year":"2005","unstructured":"Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. 2005;6(10):801\u201311. https:\/\/doi.org\/10.1038\/nrm1736","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"7653_CR82","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bbrc.2016.02.058","volume":"472","author":"Z Stickney","year":"2016","unstructured":"Stickney Z, Losacco J, McDevitt S, et al. Development of exosome surface display technology in living human cells. Biochem Biophys Res Commun. 2016;472(1):53\u201359. https:\/\/doi.org\/10.1016\/j.bbrc.2016.02.058","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"7653_CR83","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/cdd.2016.7","volume":"23","author":"S Nagata","year":"2016","unstructured":"Nagata S, Suzuki J, Segawa K, et al. Exposure of phosphatidylserine on the cell surface. Cell Death Differ. 2016;23(6):952\u201361. https:\/\/doi.org\/10.1038\/cdd.2016.7","journal-title":"Cell Death Differ"},{"issue":"1","key":"7653_CR84","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-019-0991-5","volume":"18","author":"L Mashouri","year":"2019","unstructured":"Mashouri L, Yousefi H, Aref AR, et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18(1):75. https:\/\/doi.org\/10.1186\/s12943-019-0991-5","journal-title":"Mol Cancer"},{"issue":"1","key":"7653_CR85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13045-022-01305-4","volume":"15","author":"MDA Paskeh","year":"2022","unstructured":"Paskeh MDA, Entezari M, Mirzaei S, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol. 2022;15(1):83. https:\/\/doi.org\/10.1186\/s13045-022-01305-4","journal-title":"J Hematol Oncol"},{"issue":"5\u20136","key":"7653_CR86","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s10495-023-01921-6","volume":"29","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Wang Z, Liu T, et al. Exploring the role of ITGB6: fibrosis, cancer, and other diseases. Apoptosis. 2024;29(5\u20136):570\u201385. https:\/\/doi.org\/10.1007\/s10495-023-01921-6","journal-title":"Apoptosis"},{"key":"7653_CR87","doi-asserted-by":"publisher","first-page":"579068","DOI":"10.3389\/fphar.2020.579068","volume":"11","author":"CY Su","year":"2020","unstructured":"Su CY, Li JQ, Zhang LL, et al. The biological functions and clinical applications of integrins in cancers. Front Pharmacol. 2020;11:579068. https:\/\/doi.org\/10.3389\/fphar.2020.579068","journal-title":"Front Pharmacol"},{"key":"7653_CR88","doi-asserted-by":"publisher","unstructured":"Soe ZY, Park EJ, Shimaoka M. Integrin regulation in immunological and cancerous cells and exosomes. Int J Mol Sci. 2021;22(4). https:\/\/doi.org\/10.3390\/ijms22042193","DOI":"10.3390\/ijms22042193"},{"key":"7653_CR89","doi-asserted-by":"publisher","first-page":"588066","DOI":"10.3389\/fcell.2020.588066","volume":"8","author":"EJ Park","year":"2020","unstructured":"Park EJ, Myint PK, Ito A, et al. Integrin-ligand interactions in inflammation, cancer, and metabolic disease: insights into the Multifaceted roles of an emerging ligand irisin. Front Cell Dev Biol. 2020;8:588066. https:\/\/doi.org\/10.3389\/fcell.2020.588066","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"7653_CR90","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/ijms17020171","volume":"17","author":"N Iraci","year":"2016","unstructured":"Iraci N, Leonardi T, Gessler F, et al. Focus on extracellular vesicles: physiological role and signalling properties of extracellular membrane vesicles. Int J Mol Sci. 2016;17(2):171. https:\/\/doi.org\/10.3390\/ijms17020171","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7653_CR91","doi-asserted-by":"publisher","first-page":"1996015","DOI":"10.1080\/21655979.2021.1996015","volume":"14","author":"Z Peng","year":"2023","unstructured":"Peng Z, Lu S, Lou Z, et al. Retracted article: exosomes from bone marrow mesenchymal stem cells promoted osteogenic differentiation by delivering miR-196a that targeted dickkopf-1 to activate Wnt\/\u03b2-catenin pathway. Bioengineered. 2023;14(1):1996015. https:\/\/doi.org\/10.1080\/21655979.2021.1996015","journal-title":"Bioengineered"},{"issue":"1","key":"7653_CR92","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1186\/s13018-024-05085-0","volume":"19","author":"YL Tan","year":"2024","unstructured":"Tan YL, Ju SH, Wang Q, et al. Shuanglongjiegu pill promoted bone marrow mesenchymal stem cell osteogenic differentiation by regulating the miR-217\/RUNX2 axis to activate Wnt\/\u03b2-catenin pathway. J Orthop Surg Res. 2024;19(1):617. https:\/\/doi.org\/10.1186\/s13018-024-05085-0","journal-title":"J Orthop Surg Res"},{"key":"7653_CR93","doi-asserted-by":"publisher","first-page":"101216","DOI":"10.1016\/j.bbrep.2022.101216","volume":"29","author":"M Horita","year":"2022","unstructured":"Horita M, Hsu SN, Raper A, et al. miR-29b inhibits TGF-\u03b21-induced cell proliferation in articular chondrocytes. Biochem Biophys Rep. 2022;29:101216. https:\/\/doi.org\/10.1016\/j.bbrep.2022.101216","journal-title":"Biochem Biophys Rep"},{"key":"7653_CR94","doi-asserted-by":"publisher","first-page":"891313","DOI":"10.3389\/fendo.2022.891313","volume":"13","author":"TL Ma","year":"2022","unstructured":"Ma TL, Zhu P, Ke ZR, et al. Focusing on OB-OC-M\u03a6 axis and miR-23a to explore the pathogenesis and treatment strategy of osteoporosis. Front Endocrinol (lausanne). 2022;13:891313. https:\/\/doi.org\/10.3389\/fendo.2022.891313","journal-title":"Front Endocrinol (lausanne)"},{"key":"7653_CR95","doi-asserted-by":"publisher","first-page":"18118","DOI":"10.1038\/srep18118","volume":"5","author":"X Zhang","year":"2015","unstructured":"Zhang X, Chang A, Li Y, et al. miR-140-5p regulates adipocyte differentiation by targeting transforming growth factor-\u03b2 signaling. Sci Rep. 2015;5:18118. https:\/\/doi.org\/10.1038\/srep18118","journal-title":"Sci Rep"},{"issue":"1","key":"7653_CR96","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40001-023-01034-5","volume":"28","author":"MH Gerami","year":"2023","unstructured":"Gerami MH, Khorram R, Rasoolzadegan S, et al. Emerging role of mesenchymal stem\/stromal cells (MSCs) and MSCs-derived exosomes in bone- and joint-associated musculoskeletal disorders: a new frontier. Eur J Med Res. 2023;28(1):86. https:\/\/doi.org\/10.1186\/s40001-023-01034-5","journal-title":"Eur J Med Res"},{"issue":"1","key":"7653_CR97","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13287-018-1121-9","volume":"10","author":"R Zuo","year":"2019","unstructured":"Zuo R, Liu M, Wang Y, et al. BM-MSC-derived exosomes alleviate radiation-induced bone loss by restoring the function of recipient BM-MSCs and activating Wnt\/\u03b2-catenin signaling. STEM Cell Res Ther. 2019;10(1):30. https:\/\/doi.org\/10.1186\/s13287-018-1121-9","journal-title":"STEM Cell Res Ther"},{"issue":"1","key":"7653_CR98","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/s13287-022-03204-4","volume":"13","author":"A Ahmadi","year":"2022","unstructured":"Ahmadi A, Mazloomnejad R, Kasravi M, et al. Recent advances on small molecules in osteogenic differentiation of stem cells and the underlying signaling pathways. STEM Cell Res Ther. 2022;13(1):518. https:\/\/doi.org\/10.1186\/s13287-022-03204-4","journal-title":"STEM Cell Res Ther"},{"issue":"24","key":"7653_CR99","doi-asserted-by":"publisher","first-page":"null","DOI":"10.1080\/15384101.2018.1556063","volume":"17","author":"R Wang","year":"2018","unstructured":"Wang R, Xu B, Xu H. TGF-\u03b21 promoted chondrocyte proliferation by regulating Sp1 through MSC-exosomes derived miR-135b. Cell Cycle. 2018;17(24):null. https:\/\/doi.org\/10.1080\/15384101.2018.1556063","journal-title":"Cell Cycle"},{"issue":"1","key":"7653_CR100","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12951-021-00964-8","volume":"19","author":"D Zhang","year":"2021","unstructured":"Zhang D, Wu Y, Li Z, et al. MiR-144-5p, an exosomal miRNA from bone marrow-derived macrophage in type 2 diabetes, impairs bone fracture healing via targeting Smad1. J Nanobiotechnol. 2021;19(1):226. https:\/\/doi.org\/10.1186\/s12951-021-00964-8","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"7653_CR101","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13018-023-03660-5","volume":"18","author":"H Qi","year":"2023","unstructured":"Qi H, Shen E, Shu X, et al. ERK-estrogen receptor \u03b1 signaling plays a role in the process of bone marrow mesenchymal stem cell-derived exosomes protecting against ovariectomy-induced bone loss. J Orthop Surg Res. 2023;18(1):250. https:\/\/doi.org\/10.1186\/s13018-023-03660-5","journal-title":"J Orthop Surg Res"},{"key":"7653_CR102","doi-asserted-by":"publisher","unstructured":"Lu H, Zhang Z, Wang Z, et al. Human mesenchymal stem cells-derived exosome Mimetic vesicles regulation of the MAPK pathway and ROS levels inhibits glucocorticoid-induced apoptosis in osteoblasts. STEM Cells Int. 2023, 2023;5537610. https:\/\/doi.org\/10.1155\/2023\/5537610","DOI":"10.1155\/2023\/5537610"},{"issue":"1","key":"7653_CR103","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12195-021-00699-4","volume":"15","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang Q, Su H, et al. Exosomes from Adipose tissues derived mesenchymal stem cells overexpressing MicroRNA-146a alleviate Diabetic osteoporosis in rats. Cell Mol Bioeng. 2022;15(1):87\u201397. https:\/\/doi.org\/10.1007\/s12195-021-00699-4","journal-title":"Cell Mol Bioeng"},{"key":"7653_CR104","doi-asserted-by":"publisher","unstructured":"Wang Y, Mao J, Wang Y, et al. Multifunctional exosomes derived from M2 macrophages with Enhanced odontogenesis. Neurogenesis And Angiogenesis For Regenerative Endodontic Ther: An In Vitro And In Vivo Investigation. Biomedicines. 2024;12(2). https:\/\/doi.org\/10.3390\/biomedicines12020441","DOI":"10.3390\/biomedicines12020441"},{"issue":"1","key":"7653_CR105","doi-asserted-by":"publisher","first-page":"114211","DOI":"10.1016\/j.yexcr.2024.114211","volume":"442","author":"CJC Fernandes","year":"2024","unstructured":"Fernandes CJC, Silva RA, Ferreira MR, et al. Vascular smooth muscle cell-derived exosomes promote osteoblast-to-osteocyte transition via \u03b2-catenin signaling. Exp Cell Res. 2024;442(1):114211. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114211","journal-title":"Exp Cell Res"},{"key":"7653_CR106","doi-asserted-by":"publisher","unstructured":"Park YS, Kim HW, Hwang JH, et al. Plum-derived exosome-like nanovesicles induce differentiation of osteoblasts and reduction of osteoclast activation. Nutrients. 2023;15(9). https:\/\/doi.org\/10.3390\/nu15092107","DOI":"10.3390\/nu15092107"},{"issue":"1","key":"7653_CR107","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12938-024-01237-9","volume":"23","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Li Y, Cao Z, et al. Mechanically strained osteocyte-derived exosomes contained miR-3110-5p and miR-3058-3p and promoted osteoblastic differentiation. Biomed Eng Online. 2024;23(1):44. https:\/\/doi.org\/10.1186\/s12938-024-01237-9","journal-title":"Biomed Eng Online"},{"issue":"1","key":"7653_CR108","doi-asserted-by":"publisher","first-page":"112834","DOI":"10.1016\/j.yexcr.2021.112834","volume":"408","author":"M Wang","year":"2021","unstructured":"Wang M, Zhao M, Guo Q, et al. Non-small cell lung cancer cell-derived exosomal miR-17-5p promotes osteoclast differentiation by targeting PTEN. Exp Cell Res. 2021;408(1):112834. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112834","journal-title":"Exp Cell Res"},{"issue":"6","key":"7653_CR109","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1111\/jcmm.14228","volume":"23","author":"Y Cui","year":"2019","unstructured":"Cui Y, Fu S, Sun D, et al. EPC-derived exosomes promote osteoclastogenesis through LncRNA-MALAT1. J Cell Mol Med. 2019;23(6):3843\u201354. https:\/\/doi.org\/10.1111\/jcmm.14228","journal-title":"J Cell Mol Med"},{"issue":"1","key":"7653_CR110","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s11658-024-00614-5","volume":"29","author":"J Lu","year":"2024","unstructured":"Lu J, Shi X, Fu Q, et al. New mechanistic understanding of osteoclast differentiation and bone resorption mediated by P2X7 receptors and PI3K-Akt-GSK3\u03b2 signaling. Cell Mol Biol Lett. 2024;29(1):100. https:\/\/doi.org\/10.1186\/s11658-024-00614-5","journal-title":"Cell Mol Biol Lett"},{"key":"7653_CR111","doi-asserted-by":"publisher","first-page":"109821","DOI":"10.1016\/j.abb.2023.109821","volume":"750","author":"N Uehara","year":"2023","unstructured":"Uehara N, Shibusawa N, Mikami Y, et al. Bone metastatic mammary tumor cell-derived extracellular vesicles inhibit osteoblast maturation via JNK signaling. Arch Biochem Biophys. 2023;750:109821. https:\/\/doi.org\/10.1016\/j.abb.2023.109821","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"7653_CR112","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s10020-023-00649-y","volume":"29","author":"Y Li","year":"2023","unstructured":"Li Y, Wang X, Pan C, et al. Myoblast-derived exosomal Prrx2 attenuates osteoporosis via transcriptional regulation of lncRNA-MIR22HG to activate Hippo pathway. Mol Med. 2023;29(1):54. https:\/\/doi.org\/10.1186\/s10020-023-00649-y","journal-title":"Mol Med"},{"key":"7653_CR113","doi-asserted-by":"publisher","unstructured":"Chen Y, Xiao H, Liu Z, et al. Sirt1: an increasingly interesting molecule with a potential role in bone metabolism and osteoporosis. Biomolecules. 2024;14(8). https:\/\/doi.org\/10.3390\/biom14080970","DOI":"10.3390\/biom14080970"},{"issue":"9","key":"7653_CR114","doi-asserted-by":"publisher","first-page":"e0185236","DOI":"10.1371\/journal.pone.0185236","volume":"12","author":"K Zainabadi","year":"2017","unstructured":"Zainabadi K, Liu CJ, Caldwell ALM, et al. SIRT1 is a positive regulator of in vivo bone mass and a therapeutic target for osteoporosis. PLoS One. 2017;12(9):e0185236. https:\/\/doi.org\/10.1371\/journal.pone.0185236","journal-title":"PLoS One"},{"issue":"1","key":"7653_CR115","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/s11033-024-09406-8","volume":"51","author":"N Zhu","year":"2024","unstructured":"Zhu N, Hou J, Si J, et al. SIRT1 and ZNF350 as novel biomarkers for osteoporosis: a bioinformatics analysis and experimental validation. Mol Biol Rep. 2024;51(1):530. https:\/\/doi.org\/10.1007\/s11033-024-09406-8","journal-title":"Mol Biol Rep"},{"key":"7653_CR116","doi-asserted-by":"publisher","first-page":"10872","DOI":"10.1038\/ncomms10872","volume":"7","author":"D Li","year":"2016","unstructured":"Li D, Liu J, Guo B, et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat Commun. 2016;7:10872. https:\/\/doi.org\/10.1038\/ncomms10872","journal-title":"Nat Commun"},{"issue":"1","key":"7653_CR117","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nm.3026","volume":"19","author":"X Wang","year":"2013","unstructured":"Wang X, Guo B, Li Q, et al. miR-214 targets ATF4 to inhibit bone formation. Nat Med. 2013;19(1):93\u2013100. https:\/\/doi.org\/10.1038\/nm.3026","journal-title":"Nat Med"},{"issue":"4","key":"7653_CR118","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.bone.2006.11.005","volume":"40","author":"L Bakiri","year":"2007","unstructured":"Bakiri L, Takada Y, Radolf M, et al. Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation. Bone. 2007;40(4):867\u201375. https:\/\/doi.org\/10.1016\/j.bone.2006.11.005","journal-title":"Bone"},{"issue":"2","key":"7653_CR119","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/jbmr.2032","volume":"29","author":"C Chen","year":"2014","unstructured":"Chen C, Cheng P, Xie H, et al. MiR-503 regulates osteoclastogenesis via targeting rank. J Bone Min Res. 2014;29(2):338\u201347. https:\/\/doi.org\/10.1002\/jbmr.2032","journal-title":"J Bone Min Res"},{"key":"7653_CR120","doi-asserted-by":"publisher","first-page":"594247","DOI":"10.3389\/fbioe.2020.594247","volume":"8","author":"X Xie","year":"2020","unstructured":"Xie X, Xiong Y, Panayi AC, et al. Exosomes as a novel approach to reverse osteoporosis: a review of the literature. Front Bioeng Biotechnol. 2020;8:594247. https:\/\/doi.org\/10.3389\/fbioe.2020.594247","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"7653_CR121","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s11658-022-00384-y","volume":"27","author":"The role of macrophage subtypes and exosomes in immunomodulation","year":"2022","unstructured":"The role of macrophage subtypes and exosomes in immunomodulation. Cell Mol Biol Lett. 2022;27(1):83. https:\/\/doi.org\/10.1186\/s11658-022-00384-y","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"7653_CR122","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12964-020-00650-6","volume":"18","author":"K Asgarpour","year":"2020","unstructured":"Asgarpour K, Shojaei Z, Amiri F, et al. Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages. Cell Commun Signal. 2020;18(1):149. https:\/\/doi.org\/10.1186\/s12964-020-00650-6","journal-title":"Cell Commun Signal"},{"issue":"7","key":"7653_CR123","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1021\/acscentsci.9b01235","volume":"6","author":"H Xiao","year":"2020","unstructured":"Xiao H, Guo Y, Li B, et al. M2-like tumor-associated macrophage-targeted Codelivery of STAT6 inhibitor and IKK\u03b2 siRNA induces M2-to-M1 repolarization for cancer immunotherapy with low immune side effects. ACS Cent Sci. 2020;6(7):1208\u201322. https:\/\/doi.org\/10.1021\/acscentsci.9b01235","journal-title":"ACS Cent Sci"},{"issue":"12","key":"7653_CR124","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/cbin.11690","volume":"45","author":"L Yu","year":"2021","unstructured":"Yu L, Hu M, Cui X, et al. M1 macrophage-derived exosomes aggravate bone loss in postmenopausal osteoporosis via a microRNA-98\/DUSP1\/JNK axis. Cell Biol Int. 2021;45(12):2452\u201363. https:\/\/doi.org\/10.1002\/cbin.11690","journal-title":"Cell Biol Int"},{"issue":"1","key":"7653_CR125","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12951-022-01314-y","volume":"20","author":"X Chen","year":"2022","unstructured":"Chen X, Wan Z, Yang L, et al. Exosomes derived from reparative M2-like macrophages prevent bone loss in murine periodontitis models via IL-10 mRNA. J Nanobiotechnol. 2022;20(1):110. https:\/\/doi.org\/10.1186\/s12951-022-01314-y","journal-title":"J Nanobiotechnol"},{"key":"7653_CR126","doi-asserted-by":"publisher","first-page":"rbad075","DOI":"10.1093\/rb\/rbad075","volume":"10","author":"X Luo","year":"2023","unstructured":"Luo X, Meng C, Zhang Y, et al. MicroRNA-21a-5p-modified macrophage exosomes as natural nanocarriers promote bone regeneration by targeting GATA2. Regen Biomater. 2023;10:rbad075. https:\/\/doi.org\/10.1093\/rb\/rbad075","journal-title":"Regen Biomater"},{"issue":"2","key":"7653_CR127","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/rheumatology\/keg447","volume":"43","author":"D O\u2019Gradaigh","year":"2004","unstructured":"O\u2019Gradaigh D, Compston JE. T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion. Rheumatol (Oxford). 2004;43(2):122\u201330. https:\/\/doi.org\/10.1093\/rheumatology\/keg447","journal-title":"Rheumatol (Oxford)"},{"key":"7653_CR128","doi-asserted-by":"publisher","unstructured":"Yang M, Zhu L. Osteoimmunology: the crosstalk between T cells, B cells, and osteoclasts in rheumatoid arthritis. Int J Mol Sci. 2024;25(5). https:\/\/doi.org\/10.3390\/ijms25052688","DOI":"10.3390\/ijms25052688"},{"issue":"1","key":"7653_CR129","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00018-024-05371-4","volume":"81","author":"F Wu","year":"2024","unstructured":"Wu F, Song C, Zhen G, et al. Exosomes derived from BMSCs in osteogenic differentiation promote type H blood vessel angiogenesis through miR-150-5p mediated metabolic reprogramming of endothelial cells. Cell Mol Life Sci. 2024;81(1):344. https:\/\/doi.org\/10.1007\/s00018-024-05371-4","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"7653_CR130","doi-asserted-by":"publisher","first-page":"6991","DOI":"10.1007\/s12274-022-5275-5","volume":"16","author":"X Ma","year":"2023","unstructured":"Ma X, Liu B, Fan L, et al. Native and engineered exosomes for inflammatory disease. Nano Res. 2023;16(5):6991\u20137006. https:\/\/doi.org\/10.1007\/s12274-022-5275-5","journal-title":"Nano Res"},{"key":"7653_CR131","doi-asserted-by":"publisher","first-page":"811971","DOI":"10.3389\/fbioe.2021.811971","volume":"9","author":"J Chen","year":"2021","unstructured":"Chen J, Li P, Zhang T, et al. Review on strategies and technologies for exosome isolation and purification. Front Bioeng Biotechnol. 2021;9:811971. https:\/\/doi.org\/10.3389\/fbioe.2021.811971","journal-title":"Front Bioeng Biotechnol"},{"issue":"7","key":"7653_CR132","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s00216-022-04174-5","volume":"415","author":"TS Martins","year":"2023","unstructured":"Martins TS, Vaz M, Henriques AG. A review on comparative studies addressing exosome isolation methods from body fluids. Anal Bioanal Chem. 2023;415(7):1239\u201363. https:\/\/doi.org\/10.1007\/s00216-022-04174-5","journal-title":"Anal Bioanal Chem"},{"key":"7653_CR133","doi-asserted-by":"publisher","first-page":"102121","DOI":"10.1016\/j.tranon.2024.102121","volume":"50","author":"N Dilsiz","year":"2024","unstructured":"Dilsiz N. A comprehensive review on recent advances in exosome isolation and characterization: toward clinical applications. Transl Oncol. 2024;50:102121. https:\/\/doi.org\/10.1016\/j.tranon.2024.102121","journal-title":"Transl Oncol"},{"issue":"1","key":"7653_CR134","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12951-022-01400-1","volume":"20","author":"G Zheng","year":"2022","unstructured":"Zheng G, Ma HW, Xiang GH, et al. Bone-targeting delivery of platelet lysate exosomes ameliorates glucocorticoid-induced osteoporosis by enhancing bone-vessel coupling. J Nanobiotechnol. 2022;20(1):220. https:\/\/doi.org\/10.1186\/s12951-022-01400-1","journal-title":"J Nanobiotechnol"},{"issue":"10","key":"7653_CR135","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1021\/acs.bioconjchem.9b00587","volume":"30","author":"S Shi","year":"2019","unstructured":"Shi S, Li T, Wen X, et al. Copper-64 Labeled PEGylated exosomes for in vivo positron emission Tomography and Enhanced tumor Retention. Bioconjug Chem. 2019;30(10):2675\u201383. https:\/\/doi.org\/10.1021\/acs.bioconjchem.9b00587","journal-title":"Bioconjug Chem"},{"issue":"6","key":"7653_CR136","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1021\/acsabm.2c00246","volume":"5","author":"S Baek","year":"2022","unstructured":"Baek S, Jeon M, Jung HN, et al. M1 macrophage-derived exosome-Mimetic nanovesicles with an Enhanced cancer targeting ability. ACS Appl Bio Mater. 2022;5(6):2862\u201369. https:\/\/doi.org\/10.1021\/acsabm.2c00246","journal-title":"ACS Appl Bio Mater"},{"key":"7653_CR137","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jconrel.2025.01.029","volume":"379","author":"Z Guo","year":"2025","unstructured":"Guo Z, Zhang Y, Gong Y, et al. Antibody functionalized curcuma-derived extracellular vesicles loaded with doxorubicin overcome therapy-induced senescence and enhance chemotherapy. J Control Release. 2025;379:377\u201389. https:\/\/doi.org\/10.1016\/j.jconrel.2025.01.029","journal-title":"J Control Release"},{"issue":"10","key":"7653_CR138","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1021\/bc500291r","volume":"25","author":"T Smyth","year":"2014","unstructured":"Smyth T, Petrova K, Payton NM, et al. Surface functionalization of exosomes using click chemistry. Bioconjug Chem. 2014;25(10):1777\u201384. https:\/\/doi.org\/10.1021\/bc500291r","journal-title":"Bioconjug Chem"},{"key":"7653_CR139","doi-asserted-by":"publisher","unstructured":"Li N, Qiu S, Fang Y, et al. Comparison of linear vs. Cyclic RGD pentapeptide interactions with integrin \u03b1 v \u03b2 3 by molecular dynamics simulations. Biol (Basel). 2021;10(7). https:\/\/doi.org\/10.3390\/biology10070688","DOI":"10.3390\/biology10070688"},{"issue":"3","key":"7653_CR140","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1515\/ejnm-2015-0005","volume":"7","author":"G Milosevits","year":"2015","unstructured":"Milosevits G, Szebeni J, Krol S. Exosomes: potential model for complement-stealth delivery systems. Eur J Nanomed. 2015;7(3):0\u20130. https:\/\/doi.org\/10.1515\/ejnm-2015-0005","journal-title":"Eur J Nanomed"},{"issue":"6","key":"7653_CR141","doi-asserted-by":"publisher","first-page":"null","DOI":"10.3390\/mi10060392","volume":"10","author":"FS Iliescu","year":"2019","unstructured":"Iliescu FS, Vrta\u010dnik D, Neuzil P, et al. Microfluidic technology for clinical applications of exosomes. Micromachines (basel). 2019;10(6):null. https:\/\/doi.org\/10.3390\/mi10060392","journal-title":"Micromachines (basel)"},{"key":"7653_CR142","doi-asserted-by":"publisher","first-page":"113690","DOI":"10.1016\/j.biopha.2022.113690","volume":"155","author":"NF Hosseini","year":"2022","unstructured":"Hosseini NF, Amini R, Ramezani M, et al. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer. Biomed Pharmacother. 2022;155:113690. https:\/\/doi.org\/10.1016\/j.biopha.2022.113690","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"7653_CR143","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/s25030848","volume":"25","author":"J Hu","year":"2025","unstructured":"Hu J, Gao D. Recent advances in Aptamer-based Microfluidic Biosensors for the isolation, Signal amplification and detection of exosomes. Sensors. 2025;25(3):848. https:\/\/doi.org\/10.3390\/s25030848","journal-title":"Sensors"},{"issue":"4","key":"7653_CR144","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1021\/acs.biomac.1c01636","volume":"23","author":"SS Yerneni","year":"2022","unstructured":"Yerneni SS, Lathwal S, Cuthbert J, et al. Controlled Release of exosomes using atom transfer radical polymerization-based hydrogels. Biomacromolecules. 2022;23(4):1713\u201322. https:\/\/doi.org\/10.1021\/acs.biomac.1c01636","journal-title":"Biomacromolecules"},{"key":"7653_CR145","doi-asserted-by":"publisher","unstructured":"Xie Y, Papadopoulou P, de Wit B, et al. Two types of Liposomal formulations improve the therapeutic ratio of prednisolone phosphate in a zebrafish model for inflammation. Cells. 2022;11(4). https:\/\/doi.org\/10.3390\/cells11040671","DOI":"10.3390\/cells11040671"},{"issue":"10","key":"7653_CR146","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1007\/s12274-018-2083-z","volume":"11","author":"DM Valcourt","year":"2018","unstructured":"Valcourt DM, Harris J, Riley RS, et al. Advances in targeted nanotherapeutics: from bioconjugation to biomimicry. Nano Res. 2018;11(10):4999\u20135016. https:\/\/doi.org\/10.1007\/s12274-018-2083-z","journal-title":"Nano Res"},{"issue":"5","key":"7653_CR147","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.biomaterials.2013.10.072","volume":"35","author":"YP Yu","year":"2014","unstructured":"Yu YP, Wang Q, Liu YC, et al. Molecular basis for the targeted binding of RGD-containing peptide to integrin \u03b1V\u03b23. Biomaterials. 2014;35(5):1667\u201375. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.10.072","journal-title":"Biomaterials"},{"key":"7653_CR148","doi-asserted-by":"publisher","first-page":"110236","DOI":"10.1016\/j.biopha.2020.110236","volume":"128","author":"X Lv","year":"2020","unstructured":"Lv X, Zhang C, Shuaizhen Q, et al. Design of integrin \u03b1 v \u03b2 3 targeting self-assembled protein nanoparticles with RGD peptide. Biomed Pharmacother. 2020;128:110236. https:\/\/doi.org\/10.1016\/j.biopha.2020.110236","journal-title":"Biomed Pharmacother"},{"key":"7653_CR149","doi-asserted-by":"publisher","first-page":"773636","DOI":"10.3389\/fbioe.2021.773636","volume":"9","author":"M Yang","year":"2021","unstructured":"Yang M, Zhang ZC, Liu Y, et al. Function and mechanism of RGD in bone and cartilage tissue engineering. Front Bioeng Biotechnol. 2021;9:773636. https:\/\/doi.org\/10.3389\/fbioe.2021.773636","journal-title":"Front Bioeng Biotechnol"},{"key":"7653_CR150","doi-asserted-by":"publisher","first-page":"118875","DOI":"10.1016\/j.carbpol.2021.118875","volume":"280","author":"T Mohan","year":"2022","unstructured":"Mohan T, Kleinschek KS, Kargl R. Polysaccharide peptide conjugates: chemistry, properties and applications. Carbohydr Polym. 2022;280:118875. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118875","journal-title":"Carbohydr Polym"},{"key":"7653_CR151","doi-asserted-by":"publisher","unstructured":"Silva SK, Plepis AMG, Martins VDCA, et al. Suitability of chitosan scaffolds with carbon nanotubes for bone defects treated with photobiomodulation. Int J Mol Sci. 2022;23(12). https:\/\/doi.org\/10.3390\/ijms23126503","DOI":"10.3390\/ijms23126503"},{"key":"7653_CR152","first-page":"349","volume":"60","author":"S Shi","year":"2019","unstructured":"Shi S, Wen X, Li T, et al. Radiolabeled PEGylated exosomes for in vivo pet imaging and Enhanced tumor Retention. The J Nucl Med. 2019;60349\u2013349. doi: null","journal-title":"The J Nucl Med"},{"issue":"2","key":"7653_CR153","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/08982104.2016.1274756","volume":"28","author":"D Guzman-Villanueva","year":"2018","unstructured":"Guzman-Villanueva D, Migrino RQ, Truran S, et al. Pegylated-nanoliposomal clusterin for amyloidogenic light chain-induced endothelial dysfunction. J Liposome Res. 2018;28(2):97\u2013105. https:\/\/doi.org\/10.1080\/08982104.2016.1274756","journal-title":"J Liposome Res"},{"issue":"10","key":"7653_CR154","doi-asserted-by":"publisher","first-page":"null","DOI":"10.3390\/ijms21103641","volume":"21","author":"BD Cardoso","year":"2020","unstructured":"Cardoso BD, Rodrigues ARO, Almeida BG, et al. Stealth magnetoliposomes based on calcium-substituted magnesium ferrite nanoparticles for curcumin transport and Release. Int J Mol Sci. 2020;21(10):null. https:\/\/doi.org\/10.3390\/ijms21103641","journal-title":"Int J Mol Sci"},{"issue":"6","key":"7653_CR155","doi-asserted-by":"publisher","first-page":"null","DOI":"10.3390\/md18060325","volume":"18","author":"J Liu","year":"2020","unstructured":"Liu J, Tagami T, Ozeki T. Fabrication of 3D-Printed fish-gelatin-based polymer Hydrogel patches for local delivery of PEGylated Liposomal doxorubicin. Mar Drugs. 2020;18(6):null. https:\/\/doi.org\/10.3390\/md18060325","journal-title":"Mar Drugs"},{"key":"7653_CR156","doi-asserted-by":"publisher","unstructured":"Lathwal S, Yerneni SS, Boye S, et al. Engineering exosome polymer hybrids by atom transfer radical polymerization. Proc Natl Acad Sci U S A. 2021, 2;118. https:\/\/doi.org\/10.1073\/pnas.2020241118","DOI":"10.1073\/pnas.2020241118"},{"issue":"10","key":"7653_CR157","doi-asserted-by":"publisher","first-page":"2002787","DOI":"10.1002\/advs.202002787","volume":"8","author":"C Gong","year":"2021","unstructured":"Gong C, Zhang X, Shi M, et al. Tumor exosomes reprogrammed by low pH are efficient targeting vehicles for smart drug delivery and personalized therapy against their homologous tumor. Adv Sci (Weinh). 2021;8(10):2002787. https:\/\/doi.org\/10.1002\/advs.202002787","journal-title":"Adv Sci (Weinh)"},{"key":"7653_CR158","doi-asserted-by":"publisher","unstructured":"McAndrews KM, Xiao F, Chronopoulos A, et al. Exosome-mediated delivery of CRISPR\/Cas9 for targeting of oncogenic kras G12D in pancreatic cancer. Life Sci Alliance. 2021;4(9). https:\/\/doi.org\/10.26508\/lsa.202000875","DOI":"10.26508\/lsa.202000875"},{"key":"7653_CR159","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jare.2021.11.018","volume":"40","author":"N Guo","year":"2022","unstructured":"Guo N, Liu JB, Li W, et al. The power and the promise of CRISPR\/Cas9 genome editing for clinical application with gene therapy. J Adv Res. 2022;40:135\u201352. https:\/\/doi.org\/10.1016\/j.jare.2021.11.018","journal-title":"J Adv Res"},{"issue":"15","key":"7653_CR160","doi-asserted-by":"publisher","first-page":"9874","DOI":"10.1021\/acs.chemrev.6b00799","volume":"117","author":"HX Wang","year":"2017","unstructured":"Wang HX, Li M, Lee CM, et al. CRISPR\/Cas9-based genome editing for disease modeling and therapy: challenges and opportunities for nonviral delivery. Chem Rev. 2017;117(15):9874\u2013906. https:\/\/doi.org\/10.1021\/acs.chemrev.6b00799","journal-title":"Chem Rev"},{"key":"7653_CR161","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.biomaterials.2018.04.031","volume":"171","author":"L Li","year":"2018","unstructured":"Li L, Hu S, Chen X. Non-viral delivery systems for CRISPR\/Cas9-based genome editing: challenges and opportunities. Biomaterials. 2018;171:207\u201318. https:\/\/doi.org\/10.1016\/j.biomaterials.2018.04.031","journal-title":"Biomaterials"},{"key":"7653_CR162","doi-asserted-by":"publisher","first-page":"1093607","DOI":"10.3389\/fimmu.2022.1093607","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Wang S, Sun M, et al. Exosomes as smart drug delivery vehicles for cancer immunotherapy. Front Immunol. 2022;13:1093607. https:\/\/doi.org\/10.3389\/fimmu.2022.1093607","journal-title":"Front Immunol"},{"issue":"16","key":"7653_CR163","doi-asserted-by":"publisher","first-page":"e2312559","DOI":"10.1002\/adma.202312559","volume":"36","author":"M Chen","year":"2024","unstructured":"Chen M, Lu Y, Liu Y, et al. Injectable microgels with hybrid exosomes of chondrocyte-targeted FGF18 gene-editing and self-renewable lubrication for osteoarthritis therapy. Adv Mater. 2024;36(16):e2312559. https:\/\/doi.org\/10.1002\/adma.202312559","journal-title":"Adv Mater"},{"issue":"11","key":"7653_CR164","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.7150\/thno.69368","volume":"12","author":"Y Liang","year":"2022","unstructured":"Liang Y, Xu X, Xu L, et al. Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment. Theranostics. 2022;12(11):4866\u201378. https:\/\/doi.org\/10.7150\/thno.69368","journal-title":"Theranostics"},{"key":"7653_CR165","doi-asserted-by":"publisher","first-page":"110610","DOI":"10.1016\/j.compositesb.2023.110610","volume":"255","author":"H Liu","year":"2023","unstructured":"Liu H, Zhang H, Wang S, et al. Bone-targeted bioengineered bacterial extracellular vesicles delivering siRNA to ameliorate osteoporosis. Compos Part B: Eng. 2023;255110610\u2013110610. https:\/\/doi.org\/10.1016\/j.compositesb.2023.110610","journal-title":"Compos Part B: Eng"},{"issue":"1","key":"7653_CR166","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1080\/10717544.2022.2142700","volume":"29","author":"AA Ashour","year":"2022","unstructured":"Ashour AA, El-Kamel AH, Mehanna RA, et al. Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis. Drug Deliv. 2022;29(1):3270\u201380. https:\/\/doi.org\/10.1080\/10717544.2022.2142700","journal-title":"Drug Deliv"},{"key":"7653_CR167","doi-asserted-by":"publisher","first-page":"8331","DOI":"10.2147\/IJN.S263956","volume":"15","author":"A Thakur","year":"2020","unstructured":"Thakur A, Sidu RK, Zou H, et al. Inhibition of glioma cells\u2019 proliferation by doxorubicin-loaded exosomes via Microfluidics. Int J Nanomed. 2020;15:8331\u201343. https:\/\/doi.org\/10.2147\/IJN.S263956","journal-title":"Int J Nanomed"},{"issue":"1","key":"7653_CR168","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40824-023-00413-7","volume":"27","author":"AP Dayanandan","year":"2023","unstructured":"Dayanandan AP, Cho WJ, Kang H, et al. Emerging nano-scale delivery systems for the treatment of osteoporosis. Biomater Res. 2023;27(1):68. https:\/\/doi.org\/10.1186\/s40824-023-00413-7","journal-title":"Biomater Res"},{"key":"7653_CR169","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-024-01725-y","author":"C Villa","year":"2024","unstructured":"Villa C, Secchi V, Macchi M, et al. Magnetic-field-driven targeting of exosomes modulates immune and metabolic changes in dystrophic muscle. Nat Nanotechnol. 2024. https:\/\/doi.org\/10.1038\/s41565-024-01725-y","journal-title":"Nat Nanotechnol"},{"issue":"35","key":"7653_CR170","doi-asserted-by":"publisher","first-page":"e2102150","DOI":"10.1002\/smll.202102150","volume":"17","author":"R Hao","year":"2021","unstructured":"Hao R, Yu Z, Du J, et al. A High-throughput nanofluidic device for exosome nanoporation to develop cargo delivery vehicles. Small. 2021;17(35):e2102150. https:\/\/doi.org\/10.1002\/smll.202102150","journal-title":"Small"},{"issue":"13","key":"7653_CR171","doi-asserted-by":"publisher","first-page":"16420","DOI":"10.1021\/acsami.2c22749","volume":"15","author":"W Zhang","year":"2023","unstructured":"Zhang W, Ngo L, Tsao SC, et al. Engineered cancer-derived small extracellular vesicle-Liposome hybrid delivery System for targeted treatment of breast cancer. ACS Appl Mater Interface. 2023;15(13):16420\u201333. https:\/\/doi.org\/10.1021\/acsami.2c22749","journal-title":"ACS Appl Mater Interface"},{"key":"7653_CR172","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jconrel.2023.11.020","volume":"364","author":"W Zhan","year":"2023","unstructured":"Zhan W, Deng M, Huang X, et al. Pueraria lobata-derived exosome-like nanovesicles alleviate osteoporosis by enhacning autophagy. J Control Release. 2023;364:644\u201353. https:\/\/doi.org\/10.1016\/j.jconrel.2023.11.020","journal-title":"J Control Release"},{"key":"7653_CR173","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jconrel.2022.06.011","volume":"348","author":"S Bashyal","year":"2022","unstructured":"Bashyal S, Thapa C, Lee S. Recent progresses in exosome-based systems for targeted drug delivery to the brain. J Control Release. 2022;348:723\u201344. https:\/\/doi.org\/10.1016\/j.jconrel.2022.06.011","journal-title":"J Control Release"},{"key":"7653_CR174","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bioactmat.2021.09.015","volume":"10","author":"Y Cui","year":"2022","unstructured":"Cui Y, Guo Y, Kong L, et al. A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis. Bioact Mater. 2022;10:207\u201321. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.09.015","journal-title":"Bioact Mater"},{"issue":"6","key":"7653_CR175","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/cnma.202100154","volume":"7","author":"C Wang","year":"2021","unstructured":"Wang C, Kimura K, Li J, et al. Cover feature: Polydopamine-mediated surface functionalization of exosomes (ChemNanomat 6\/2021). ChemNanomat. 2021;7(6):562\u2013562. https:\/\/doi.org\/10.1002\/cnma.202100154","journal-title":"ChemNanomat"},{"key":"7653_CR176","doi-asserted-by":"publisher","first-page":"102667","DOI":"10.1016\/j.nano.2023.102667","volume":"50","author":"S Ellipilli","year":"2023","unstructured":"Ellipilli S, Wang H, Binzel DW, et al. Ligand-displaying-exosomes using rna nanotechnology for targeted delivery of multi-specific drugs for liver cancer regression. Nanomedicine. 2023;50:102667. https:\/\/doi.org\/10.1016\/j.nano.2023.102667","journal-title":"Nanomedicine"},{"key":"7653_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-024-01783-2","author":"X Ding","year":"2024","unstructured":"Ding X, Zhang J, Wan S, et al. Non-discriminating engineered masking of immuno-evasive ligands on tumour-derived extracellular vesicles enhances tumour vaccination outcomes. Nat Nanotechnol. 2024. https:\/\/doi.org\/10.1038\/s41565-024-01783-2","journal-title":"Nat Nanotechnol"},{"key":"7653_CR178","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.jconrel.2022.12.027","volume":"353","author":"J Mondal","year":"2023","unstructured":"Mondal J, Pillarisetti S, Junnuthula V, et al. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications. J Control Release. 2023;353:1127\u201349. https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.027","journal-title":"J Control Release"},{"issue":"20","key":"7653_CR179","doi-asserted-by":"publisher","first-page":"1900513","DOI":"10.1002\/advs.201900513","volume":"6","author":"H Kim","year":"2019","unstructured":"Kim H, Wang SY, Kwak G, et al. Exosome-guided phenotypic switch of M1 to M2 macrophages for cutaneous wound healing. Adv Sci (Weinh). 2019;6(20):1900513. https:\/\/doi.org\/10.1002\/advs.201900513","journal-title":"Adv Sci (Weinh)"},{"key":"7653_CR180","doi-asserted-by":"publisher","unstructured":"Choi H, Kim MY, Kim DH, et al. Quantitative biodistribution and pharmacokinetics study of GMP-Grade exosomes Labeled with 89 Zr radioisotope in mice and rats. Pharmaceutics. 2022;14(6). https:\/\/doi.org\/10.3390\/pharmaceutics14061118","DOI":"10.3390\/pharmaceutics14061118"},{"issue":"26","key":"7653_CR181","doi-asserted-by":"publisher","first-page":"11863","DOI":"10.7150\/thno.49069","volume":"10","author":"I Kalashnikova","year":"2020","unstructured":"Kalashnikova I, Chung SJ, Nafiujjaman M, et al. Ceria-based nanotheranostic agent for rheumatoid arthritis. Theranostics. 2020;10(26):11863\u201380. https:\/\/doi.org\/10.7150\/thno.49069","journal-title":"Theranostics"},{"issue":"4","key":"7653_CR182","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41419-023-05753-9","volume":"14","author":"H Luo","year":"2023","unstructured":"Luo H, Zhang H, Mao J, et al. Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma. Cell Death Dis. 2023;14(4):235. https:\/\/doi.org\/10.1038\/s41419-023-05753-9","journal-title":"Cell Death Dis"},{"issue":"4","key":"7653_CR183","doi-asserted-by":"publisher","first-page":"714","DOI":"10.7507\/1001-5515.201810027","volume":"37","author":"W Meng","year":"2020","unstructured":"Meng W, Li L, Zhu G. Prospects and challenges of exosomes as drug delivery systems. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020;37(4):714\u201320. https:\/\/doi.org\/10.7507\/1001-5515.201810027","journal-title":"Sheng Wu Yi Xue Gong Cheng Xue Za Zhi"},{"issue":"1","key":"7653_CR184","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40659-021-00366-y","volume":"54","author":"T Chen","year":"2021","unstructured":"Chen T, Yang T, Zhang W, et al. The therapeutic potential of mesenchymal stem cells in treating osteoporosis. Biol Res. 2021;54(1):42. https:\/\/doi.org\/10.1186\/s40659-021-00366-y","journal-title":"Biol Res"},{"issue":"1","key":"7653_CR185","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell STEM Cell. 2015;17(1):11\u201322. https:\/\/doi.org\/10.1016\/j.stem.2015.06.007","journal-title":"Cell STEM Cell"},{"issue":"1","key":"7653_CR186","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-020-01737-0","volume":"11","author":"H Cheng","year":"2020","unstructured":"Cheng H, Chang S, Xu R, et al. Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis. STEM Cell Res Ther. 2020;11(1):224. https:\/\/doi.org\/10.1186\/s13287-020-01737-0","journal-title":"STEM Cell Res Ther"},{"key":"7653_CR187","doi-asserted-by":"publisher","unstructured":"Aheget H, Trist\u00e1n-Manzano M, Mazini L, et al. Exosome: a new player in translational Nanomedicine. J Clin Med. 2020;9(8): null. doi: https:\/\/doi.org\/10.3390\/jcm9082380","DOI":"10.3390\/jcm9082380"},{"issue":"2","key":"7653_CR188","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41422-020-00409-1","volume":"31","author":"D Wei","year":"2021","unstructured":"Wei D, Zhan W, Gao Y, et al. RAB31 marks and controls an ESCRT-independent exosome pathway. Cell Res. 2021;31(2):157\u201377. https:\/\/doi.org\/10.1038\/s41422-020-00409-1","journal-title":"Cell Res"},{"issue":"5","key":"7653_CR189","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cels.2015.10.011","volume":"1","author":"MS Sherman","year":"2015","unstructured":"Sherman MS, Lorenz K, Lanier MH, et al. Cell-to-cell variability in the propensity to transcribe explains correlated fluctuations in gene expression. Cell Syst. 2015;1(5):315\u201325. https:\/\/doi.org\/10.1016\/j.cels.2015.10.011","journal-title":"Cell Syst"},{"issue":"7","key":"7653_CR190","doi-asserted-by":"publisher","first-page":"e70132","DOI":"10.1002\/jev2.70132","volume":"14","author":"A Hassanzadeh-Barforoushi","year":"2025","unstructured":"Hassanzadeh-Barforoushi A, Sango X, Johnston EL, Haylock D, Wang Y. Microfluidic devices for manufacture of therapeutic extracellular vesicles: advances and opportunities. J Extracell Vesicles. 2025;14(7):e70132. https:\/\/doi.org\/10.1002\/jev2.70132","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"7653_CR191","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41392-023-01704-0","volume":"9","author":"F Tan","year":"2024","unstructured":"Tan F, Li X, Wang Z, et al. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9(1):17. https:\/\/doi.org\/10.1038\/s41392-023-01704-0","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"7653_CR192","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41419-024-06494-z","volume":"15","author":"C Lyu","year":"2024","unstructured":"Lyu C, Sun H, Sun Z, et al. Roles of exosomes in immunotherapy for solid cancers. Cell Death Dis. 2024;15(2):106. https:\/\/doi.org\/10.1038\/s41419-024-06494-z","journal-title":"Cell Death Dis"},{"issue":"4 Suppl","key":"7653_CR193","doi-asserted-by":"publisher","first-page":"125S","DOI":"10.1016\/8756-3282(95)00285-l","volume":"17","author":"DD Thompson","year":"1995","unstructured":"Thompson DD, Simmons HA, Pirie CM, et al. FDA guidelines and animal models for osteoporosis. Bone. 1995;17(4 Suppl):125S\u201333S. https:\/\/doi.org\/10.1016\/8756-3282(95)00285-l","journal-title":"Bone"},{"issue":"1","key":"7653_CR194","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/s13287-021-02415-5","volume":"12","author":"N Ebrahim","year":"2021","unstructured":"Ebrahim N, Al Saihati HA, Shaman A, et al. Bone marrow-derived mesenchymal stem cells combined with gonadotropin therapy restore postnatal oogenesis of chemo-ablated ovaries in rats via enhancing very small embryonic-like stem cells. STEM Cell Res Ther. 2021;12(1):517. https:\/\/doi.org\/10.1186\/s13287-021-02415-5","journal-title":"STEM Cell Res Ther"},{"issue":"1","key":"7653_CR195","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s10020-024-00904-w","volume":"30","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Bai J, Xiao B, et al. BMSC-derived exosomes promote osteoporosis alleviation via M2 macrophage polarization. Mol Med. 2024;30(1):220. https:\/\/doi.org\/10.1186\/s10020-024-00904-w","journal-title":"Mol Med"},{"key":"7653_CR196","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jconrel.2022.03.038","volume":"345","author":"C Yang","year":"2022","unstructured":"Yang C, Wu Y, Wang L, et al. Glioma-derived exosomes hijack the blood-brain barrier to facilitate nanocapsule delivery via LCN2. J Control Release. 2022;345:537\u201348. https:\/\/doi.org\/10.1016\/j.jconrel.2022.03.038","journal-title":"J Control Release"},{"key":"7653_CR197","doi-asserted-by":"publisher","unstructured":"Aimaletdinov AM, Gomzikova MO. Tracking of extracellular vesicles\u2019 biodistribution: new methods and approaches. Int J Mol Sci. 2022;23(19). https:\/\/doi.org\/10.3390\/ijms231911312","DOI":"10.3390\/ijms231911312"},{"key":"7653_CR198","doi-asserted-by":"publisher","first-page":"114974","DOI":"10.1016\/j.addr.2023.114974","volume":"199","author":"ZF Greenberg","year":"2023","unstructured":"Greenberg ZF, Graim KS, He M. Towards artificial intelligence-enabled extracellular vesicle precision drug delivery. Adv Drug Deliv Rev. 2023;199:114974. https:\/\/doi.org\/10.1016\/j.addr.2023.114974","journal-title":"Adv Drug Deliv Rev"},{"key":"7653_CR199","doi-asserted-by":"publisher","unstructured":"Ong W, Liu RW, Makmur A, et al. Artificial intelligence applications for osteoporosis classification using computed Tomography. Bioeng (Basel). 2023;10(12). https:\/\/doi.org\/10.3390\/bioengineering10121364","DOI":"10.3390\/bioengineering10121364"},{"issue":"4","key":"7653_CR200","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/clinem\/dgac702","volume":"108","author":"HP Dimai","year":"2023","unstructured":"Dimai HP. New horizons: artificial intelligence tools for managing osteoporosis. J Clin Endocrinol Metab. 2023;108(4):775\u201383. https:\/\/doi.org\/10.1210\/clinem\/dgac702","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07653-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07653-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07653-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:01:31Z","timestamp":1771596091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07653-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":200,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7653"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07653-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"285"}}